Name | Avotaciclib |
---|
Description | Avotaciclib (BEY1107) is an orally active cyclin dependent kinase 1 (CDK1) inhibitor. Avotaciclib can be used for the research of cancer[1]. |
---|---|
Related Catalog | |
Target |
CDK1 |
In Vitro | Avotaciclib is an orally active cyclin dependent kinase 1 (CDK1) inhibitor [1]. |
References |
Molecular Formula | C13H11N7O |
---|---|
Molecular Weight | 281.27 |